This inventor holds 1 USPTO granted patent. Top assignee: Societe Cooperative Agricole Laitiere D'artois Et Des Flandres, La. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Laurent Miclo: Innovator in Benzodiazepine-Type Activity
Introduction
Laurent Miclo is a notable inventor based in Nancy, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of medicines that utilize a specific decapeptide for therapeutic purposes. His innovative work focuses on addressing conditions such as convulsions and anxiety.
Latest Patents
Laurent Miclo holds a patent for the use of a decapeptide with benzodiazepine-type activity. This invention relates to the preparation of medicines that leverage the amino acid sequence of SEQ ID NO.:1. The patent outlines the potential applications of this decapeptide in pharmaceutical compositions, food supplements, and foodstuffs designed for special diets.
Career Highlights
Throughout his career, Laurent Miclo has been associated with the Société Coopérative Agricole Laitière D'Artois et des Flandres. His work in this organization has allowed him to explore and develop innovative solutions in the agricultural and pharmaceutical sectors.
Collaborations
Laurent Miclo has collaborated with notable colleagues, including Emmanuel Perrin and Alain Driou. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Laurent Miclo's contributions to the field of pharmaceuticals through his innovative use of decapeptides highlight his role as a significant inventor. His work continues to pave the way for advancements in treatments for anxiety and convulsions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile